Top Industry Leaders in the Radio Pharmaceutical Market
*Disclaimer: List of key companies in no particular orderLatest Radiopharmaceutical Companies Update
-
October 2023: Eclipse and GE HealthCare led an oversubscribed $56 million Series A funding round for Nucleus RadioPharma, which is the first fully integrated development, manufacturing, and supply chain organization for radiopharmaceuticals. Other investors included Echo Global, Fox Chase Cancer Center, Granger Management, Mayo Clinic, Mercy Health, and the University of Missouri. In order to research, manufacture, and distribute radiopharmaceuticals, Nucleus RadioPharma will use the proceeds from this round of fundraising to open various new production sites around the country, notably in Rochester, Minnesota, close to the Mayo Clinic. Nucleus RadioPharma will not only help create the future of manufacturing, but also of a new supply chain network that will help move, track, and distribute products to patients more quickly and effectively. Target molecules will be identified, remedies will be tested, regulatory approvals will be supported, and finally, medicine will be delivered to patients with the help of this network.
-
October 2023: Pluvicto (lutetium vipivotide tetraxetan) sales increased by 220 percent, and Novartis expects this trend to continue as a result of a positive data readout. This income gain was also 12% higher than the same period last year when adjusted for the impact of foreign exchange rates. Novartis has released its first quarterly financial results after severing relations with Sandoz, a generics medication business it formerly owned. If Novartis hadn't encountered supply problems that limited patient access for much of 2023, Pluvicto's sales increase would have been much more impressive. In addition to Pluvicto, Novartis also sells the radioligand treatment Lutathera (lutetium Lu 177 dotatate), which is used to treat some types of neuroendocrine tumors. Sales of Lutathera were $159 million in the third quarter of 2023.
List of Radiopharmaceutical Key companies in the market
- GE Healthcare
- Lantheus Medical Imaging Inc.
- Novartis AG
- BWX Technologies Inc.
- Siemens Healthineers
- IRE ELiT
- JSC Isotope
- NTP Radioisotopes SOC Ltd
- Curium
- Australian Nuclear Science and Technology Organization (ANSTO)